Clinical Trial Update: Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of Theralux Extracorporeal Photochemotherapy (ECP) for extensive chronic graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Theralux Extracorporeal Photochemotherapy (ECP)

Snippet

Sponsor: Kiadis Pharma | Conditions: Graft vs Host Disease | Phase 1, Phase 2 | Status: COMPLETED